Open AccessRapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer
Author(s) -
Tao Liu,
Xiangsen Liang,
Yu Sun,
Shengzhuang Yang
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10624
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , viability assay , biology , rptor , cell growth , sirtuin 1 , cancer research , cell cycle , downregulation and upregulation , microbiology and biotechnology , cell , signal transduction , chemistry , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom